Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benzododecinium is a quaternary ammonium compound used primarily as an antiseptic and disinfectant. It acts as a cationic surfactant, disrupting microbial cell membranes, which leads to leakage of cellular contents and cell death. Benzododecinium is effective against gram-positive bacteria and has variable activity against some gram-negative organisms; it is not effective against Mycobacterium tuberculosis or bacterial spores. It is also used as a preservative in pharmaceutical formulations, including ophthalmic solutions, where it can enhance corneal permeability. The drug has been marketed in the Czech Republic under the brand name Ajatin for wound antisepsis[1][2][4][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on benzododecinium.